Get started
Author

Ann Maria

Observed name: Maria, Ann
OpenAlex ID: A5113139554
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia
2015 · Sabine Topka, Joseph Vijai, et al. · PLoS Genetics · 159
PDF
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
2017 · Thomas P. Slavin, Kara N. Maxwell, et al. · npj Breast Cancer · 138
PDF
Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
2016 · Sonja I. Berndt, Nicola J. Camp, et al. · Nature Communications · 112
PDF
Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region
2014 · Christine F. Skibola, Sonja I. Berndt, et al. · The American Journal of Human Genetics · 110
PDF
A genome-wide association study of marginal zone lymphoma shows association to the HLA region
2015 · Joseph Vijai, Zhaoming Wang, et al. · Nature Communications · 66
PDF
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
2016 · Joseph Vijai, Sabine Topka, et al. · Cancer Discovery · 47
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
2019 · Yijun Gao, Ann Maria, et al. · Cancer Discovery · 42
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
2018 · Mary L. McMaster, Sonja I. Berndt, et al. · Nature Communications · 23
PDF
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers
2023 · Naryan Rustgi, Ann Maria, et al. · The Oncologist · 14
PDF
Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
2017 · Thomas P. Slavin, Kara N. Maxwell, et al. · npj Breast Cancer · 13
PDF
Supplementary Figures 1 - 6, Tables 1 - 2 from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
2023 · Joseph Vijai, Sabine Topka, et al.
PDF
Data from V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
2023 · Yijun Gao, Ann Maria, et al.
Supplementary Data from V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
2023 · Yijun Gao, Ann Maria, et al.
PDF
Supplementary Data from V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
2023 · Yijun Gao, Ann Maria, et al.
Data from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
2023 · Joseph Vijai, Sabine Topka, et al.
Data from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
2023 · Joseph Vijai, Sabine Topka, et al.
Data from V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer
2023 · Yijun Gao, Ann Maria, et al.
Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
2020 · Glimelius, Bengt, Machado, Moara, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Abstract 1281: Germline mutations in NBN conferring DNA damage response defects are found in patients with multiple cancer types
2017 · Sabine Topka, Michael F. Walsh, et al. · Cancer Research
Abstract 4265: Risks of familial breast cancer associated with known and proposed breast cancer susceptibility genes
2017 · Kara N. Maxwell, Thomas Paul Slavin, et al. · Cancer Research
Abstract 796: ERCC3 R109X is a moderate risk breast cancer risk variant in Ashkenazi Jews
2016 · Joseph Vijai, Sabine Topka, et al. · Cancer Research
Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region
2014 · Christine F. Skibola, Sonja I. Berndt, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
Works count: 22
Citation count: 724
H-index: 10
I10-index: 10
Year
Topic
Type